Marrow-derived mesenchymal stem cells:: Role in epithelial tumor cell determination

被引:70
作者
Fierro, FA
Sierralta, WD
Epuñan, MJ
Minguell, JJ
机构
[1] Univ Chile, Inst Nutr & Tecnol Alimentos, Programa Terapias Celulares, Santiago 11, Chile
[2] Clin Las Condes, Lab Trasplante Medula Osea, Santiago, Chile
关键词
breast cancer cells; mesenchymal stem cells; marrow stroma; micrometastases; mesenchymal-epithelial cell interaction;
D O I
10.1023/B:CLIN.0000046130.79363.33
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Marrow stroma represents an advantageous environment for development of micrometastatic cells. Within the cellular structure of marrow stroma, mesenchymal stem cells (MSC) have been postulated as an interacting target for disseminated cancer cells. The studies reported here were performed to gain more information on the interaction of the human breast cancer cell line MCF-7 with human bone marrow-derived MSC cells and to investigate whether this interaction affects tumor cell properties. The results showed that after co-culture with MSC, changes were detected in the morphology, proliferative capacity and aggregation pattern of MCF-7 cells, but these parameters were not affected after the co-culture of MSC cells with a non-tumorigenic breast epithelial cell line, MCF-10. Since the indirect culture of MCF-7 with MSC or its products also resulted in functional changes in the tumor cells, we evaluated whether these effects could be attributed to growth factors produced by MSC cells. It was found that VEGF and IL-6 mimic the effects produced by MSC or its products on the proliferation and aggregation properties of MCF-7, cells, respectively. Thus, it seems that after entry of disseminated tumor cells into the marrow space, their proliferative and morphogenetic organization patterns are modified after interaction with distinct stromal cells and/or with specific signals from the marrow microenvironment.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 29 条
[1]   The effects of IL-6 on cell adhesion and E-cadherin expression in breast cancer [J].
Asgeirsson, KS ;
Olafsdottir, K ;
Jonasson, JG ;
Ogmundsdottir, HM .
CYTOKINE, 1998, 10 (09) :720-728
[2]   Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells [J].
Benavente, CA ;
Sierralta, WD ;
Conget, PA ;
Minguell, JJ .
GROWTH FACTORS, 2003, 21 (02) :87-94
[3]  
Bischoff J, 2003, RECENT RESULTS CANC, V162, P135
[4]   Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells [J].
Borgen, E ;
Naume, B ;
Nesland, JM ;
Kvalheim, G ;
Beiske, K ;
Fodstad, O ;
Diel, I ;
Solomayer, EF ;
Theocharous, P ;
Coombes, RC ;
Smith, BM ;
Wunder, E ;
Marolleau, JP ;
Garcia, J ;
Pantel, K .
CYTOTHERAPY, 1999, 1 (05) :377-388
[5]  
Brooks B, 1997, INT J CANCER, V73, P690, DOI 10.1002/(SICI)1097-0215(19971127)73:5<690::AID-IJC13>3.0.CO
[6]  
2-A
[7]  
Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO
[8]  
2-C
[9]   Cutting edge communication - Identification of a discrete population of human bone marrow-derived mesenchymal cells exhibiting properties of uncommitted progenitors [J].
Conget, PA ;
Allers, C ;
Minguell, JJ .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (06) :749-758
[10]   gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells [J].
Erices, A ;
Conget, P ;
Rojas, C ;
Minguell, JJ .
EXPERIMENTAL CELL RESEARCH, 2002, 280 (01) :24-32